Diabetic Retinopathy Market Size And Growth Opportunities Forecast 2022-28

The research report "Diabetic Retinopathy Market by Type (Proliferative DR and Diabetic Macular Edema), Drug Class (Corticosteroids, Anti-VEGF (vascular endothelial growth factor)) Distribution Channels (Ophthalmic Clinics, Hospital Pharmacies, Retail pharmacies) Geography- Global/Region/Country Forecast to 2028." The global diabetic retinopathy market size was estimated at USD 6.24 billion in 2021, growing at a CAGR rate of 6.9% during the forthcoming years 2022-2028.

View the detailed Report Description here - https://precisionbusinessinsights.com/market-reports/global-diabetic-retinopathy-market/

Increasing healthcare infrastructure fuels the Diabetic Retinopathy Market:
Diabetic retinopathy is one of the most common forms of diabetic eye disease and mostly affects people suffering from diabetes from several years. The main manifestation in diabetic retinopathy is the high glucose levels, which cause damage to the retinal blood vessels. In a few cases, the surface of the retinal blood vessels will grow abnormally and in some cases, the retinal blood vessels will be swollen with a fluid leaking into rear of eye. It is the major cause of blindness in adult population in America and 347 Mn people were suffering from diabetes and among which 11% population went through diabetic retinopathy problem in 2012 globally according to the World Health Organization (WHO).

There is abundant increase in the diabetic patients and 41% of global population with diabetes is aged patients which is greatly attributing to the diabetic retinopathy market growth according to the World Health Organization. Both type 1 and type 2 diabetic patients will be affected by diabetic retinopathy. Moreover, growing demand for the early diagnosis devices and increase in healthcare infrastructure up-gradation are some other factors contribute greatly in boosting the diabetic retinopathy market. On the other hand, lack of insurance facilities and primary infrastructure and paucity of skilled ophthalmologist hinder the diabetic retinopathy market growth.

North America accounts for major share in the Diabetic Retinopathy Market:
On the basis of regional analysis, the global diabetic retinopathy market has been categorized into major regions such as Asia Pacific, Latin America, North America, Europe, Middle East and Africa. Followed by Europe and Asia Pacific, North America is leading the market among all these regions. High obesity rates in people are one of the major factors driving the North America market growth. Europe market anticipated to bolster due to the large patient pool with diabetic retinopathy. There are some factors boosting the Asia Pacific diabetic retinopathy market growth such as increasing preference towards early detection and treatment of chronic conditions including diabetic retinopathy, growing consciousness among people due to the improved infrastructure and improving on the quality of life (QALY) in diabetic people.

Request sample report at https://precisionbusinessinsights.com/request-sample?product_id=16121

Competitive Analysis - Diabetic Retinopathy Market
A few major players working in the diabetic retinopathy market are Abbott Laboratories (U.S.), Alimera Sciences (U.S.), Allergan plc (Ireland.), Ampio Pharmaceuticals. (U.S.), Bayer AG (Germany), F. Hoffmann-La Roche (Switzerland), Novartis AG (Switzerland), Pfizer Inc. (U.S.), Regeneron Pharmaceuticals Inc. (U.S.) and Valeant (Canada).

Contact:
Mr. Satya
Precision Business InsightsTM | Toll Free: +1 866 598 1553
Email: sales@precisionbusinessinsights.com
Kemp House, 152 - 160 City Road, London EC1V 2NX
Web: https://precisionbusinessinsights.com/ | D U N S® Number: 852781747

About Precision Business Insights:
We are a market research company that strives to provide the highest quality market research insights. Our diverse market research experts are enthusiastic about market research and therefore produce high-quality research reports. We have over 500 clients with whom we have a good business partnership and capacity to provide in-depth research analysis for more than 30 countries. In addition to deliver more than 150 custom solutions, we already have accounts with the top five medical device manufacturers.

Precision Business Insights offers a variety of cost-effective and customized research services to meet research requirements. We are a leading research service provider because of our extensive database built by our experts and the services we provide.

This release was published on openPR.